Raphael Pharmaceutical Inc. (RAPH) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $53.0K | +96.3% |
| 2024 | $27.0K | -88.7% |
| 2023 | $239.0K | -28.2% |
| 2022 | $333.0K | -21.1% |
| 2021 | $422.0K | +30.7% |
| 2020 | $323.0K | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $53.0K | +96.3% |
| 2024 | $27.0K | -88.7% |
| 2023 | $239.0K | -28.2% |
| 2022 | $333.0K | -21.1% |
| 2021 | $422.0K | +30.7% |
| 2020 | $323.0K | — |